Earnings FeedTerminal

⌘K

Home/Filings/8-K/0001558370-16-006280

8-K//Current report

Adamas Pharmaceuticals Inc 8-K

Accession 0001558370-16-006280

CIK 0001328143operating

View on SEC.gov Company Profile

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 12:10 PM ET

Size

45.7 KB

Accession

0001558370-16-006280

Documents

1 file

8-K
adms-20160603x8k.htmPrimary
8-K

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001328143

Filing Metadata

Form type: 8-K
Filed: Jun 5, 8:00 PM ET
Accepted: Jun 6, 12:10 PM ET
Size: 45.7 KB

View on SEC.gov